Aktis Oncology, which recently had its IPO, has gained substantial backing from Big Pharma mainstay Eli Lilly. Investors ...

Learn about Minority IPOs, their benefits in revealing true subsidiary value, and an example of how they can strategically benefit parent companies without losing control.

Using Crunchbase’s predictive intelligence tools — which evaluate factors including funding history, growth signals, investor ...

Discover how reverse greenshoe options stabilize IPO prices, including their function, examples, and historical background, ...

Prism files IPO draft papers with SEBI to raise INR 6.6 billion, potentially valuing the company at $7-8 billion.

In this Super IPO 2.0 review, I break down Altucher’s thesis so you can decide whether his approach is worth a closer look.

Getting ready for the stock market in 2026? Especially if you’re looking at medical technology companies, things ...

After a shaky start to the year due to uncertainty about the Trump administration's tariffs and stock market volatility in the spring, activity in the initial public offering (IPO) market picked up in ...

If you are new to investing, the idea of primary vs secondary markets can feel confusing at first. You may hear about companies going public, IPOs making ...

Baidu plans a Hong Kong IPO spin-off of AI chip unit Kunlunxin, boosting valuation as AI/Cloud growth accelerates. See why ...